Kasper Møller
Chief Tech/Sci/R&D Officer at MOLMED S.P.A.
Profile
Kasper Møller is currently the Chief Technical Officer at AGC Biologics SpA since 2019.
He is also the Chief Technology Officer at AGC Biologics A since 2006.
Previously, he worked as a Faculty Member at the Technical University of Denmark.
Dr. Møller holds a doctorate degree from the Technical University of Denmark, which he obtained in 2001.
He also has a graduate degree from Washington University School of Medicine.
Kasper Møller active positions
Companies | Position | Start |
---|---|---|
MOLMED S.P.A. | Chief Tech/Sci/R&D Officer | 2019-05-31 |
AGC Biologics A/S
AGC Biologics A/S Pharmaceuticals: MajorHealth Technology AGC Biologics A/S provides contract process development and biopharmaceuticals manufacturing services worldwide. It specializes in delivering custom solutions for the scale-up and the cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials, and commercial production. Its services include cell line development, bioprocess development, formulation, and analytical testing. The company was founded by Peter Vilby, Mads Laustsen, Thomas Sandal, and Morten Munk in 2001 and is headquartered in Soeborg, Denmark. | Chief Tech/Sci/R&D Officer | 2019-06-03 |
Former positions of Kasper Møller
Companies | Position | End |
---|---|---|
Technical University of Denmark | Corporate Officer/Principal | - |
Training of Kasper Møller
Technical University of Denmark | Doctorate Degree |
Washington University School of Medicine | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
AGC Biologics SpA
AGC Biologics SpA Pharmaceuticals: MajorHealth Technology AGC Biologics SpA engages in the research, development, manufacturing, and clinical validation of cell and gene therapies for the treatment of cancer and rare diseases. Its approach is based on finding drugs that target the reduction of tumor mass in the acute stage, as well as on the provision of selective therapies to eliminate the residual disease. It also conducts cell and gene therapy projects in collaboration with third parties, offering resources and expertise covering preclinical to Phase III trial activities. The company was founded by Claudio Bordignon on July 11, 1996 and is headquartered in Milan, Italy. | Health Technology |
AGC Biologics A/S
AGC Biologics A/S Pharmaceuticals: MajorHealth Technology AGC Biologics A/S provides contract process development and biopharmaceuticals manufacturing services worldwide. It specializes in delivering custom solutions for the scale-up and the cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials, and commercial production. Its services include cell line development, bioprocess development, formulation, and analytical testing. The company was founded by Peter Vilby, Mads Laustsen, Thomas Sandal, and Morten Munk in 2001 and is headquartered in Soeborg, Denmark. | Health Technology |
- Stock Market
- Insiders
- Kasper Møller